Ascent Group’s Idexx Laboratories IDXX Stock Holding History

Ascent Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$342K	Sell	609 -112	-16%	-$71.8K	0.01%	585
2025 Q4	$488K	Buy	721 +89	+14%	+$60.6K	0.02%	499
2025 Q3	$404K	Buy	632 +18	+3%	+$10.9K	0.01%	538
2025 Q2	$329K	Sell	614 -103	-14%	-$49.3K	0.01%	560
2025 Q1	$301K	Buy	+717	New	+$311K	0.01%	559
2022 Q3	–	Sell	-615	Closed	-$245K	–	482
2022 Q2	$245K	Sell	615 -147	-19%	-$59.9K	0.03%	423
2022 Q1	$417K	Buy	762 +226	+42%	+$119K	0.05%	349
2021 Q4	$269K	Buy	+536	New	+$336K	0.03%	392

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ascent Group's IDXX Position: Q1 2026 in Review

Ascent Group reduced its Idexx Laboratories (IDXX) stake by 16% in Q1 2026, selling an estimated $71.8K and leaving 609 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #585.

Ascent Group first reported a position in IDXX in Q4 2021 and has held it in 8 quarters since. The position peaked at $488K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Ascent Group held 609 shares of Idexx Laboratories worth $342K as of Q1 2026.
Ascent Group sold 112 Idexx Laboratories shares in Q1 2026, an estimated $71.8K.
Idexx Laboratories made up 0.01% of Ascent Group's portfolio in Q1 2026, its #585 holding.
Ascent Group first reported a position in Idexx Laboratories in Q4 2021 and has held it in 8 quarters since.
Ascent Group's Idexx Laboratories position peaked at $488K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.